Ian A. Strohbehn

3.4k total citations
28 papers, 592 citations indexed

About

Ian A. Strohbehn is a scholar working on Oncology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ian A. Strohbehn has authored 28 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Infectious Diseases and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ian A. Strohbehn's work include COVID-19 Clinical Research Studies (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Hepatitis C virus research (5 papers). Ian A. Strohbehn is often cited by papers focused on COVID-19 Clinical Research Studies (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Hepatitis C virus research (5 papers). Ian A. Strohbehn collaborates with scholars based in United States and Germany. Ian A. Strohbehn's co-authors include Meghan E. Sise, Harish Seethapathy, Kerry L. Reynolds, David E. Leaf, Sophia Zhao, Donald F. Chute, Ryan J. Sullivan, Leyre Zubiri, Alexandra–Chloé Villani and Frank B. Cortazar and has published in prestigious journals such as PLoS ONE, Journal of the American Society of Nephrology and American Journal of Kidney Diseases.

In The Last Decade

Ian A. Strohbehn

26 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian A. Strohbehn United States	12	325	173	135	103	67	28	592
Harish Seethapathy United States	15	416 1.3×	252 1.5×	172 1.3×	48 0.5×	106 1.6×	40	751
Masahiro Kawada Japan	14	100 0.3×	138 0.8×	214 1.6×	81 0.8×	95 1.4×	71	624
Luís Corral-Gudino Spain	13	264 0.8×	219 1.3×	30 0.2×	135 1.3×	35 0.5×	57	665
E. Cassuto‐Viguier France	13	232 0.7×	155 0.9×	127 0.9×	69 0.7×	210 3.1×	35	1.0k
Johnny Sayegh France	15	91 0.3×	163 0.9×	134 1.0×	45 0.4×	205 3.1×	34	661
Purva Sharma United States	8	61 0.2×	131 0.8×	190 1.4×	283 2.7×	130 1.9×	22	506
Sławomir Zmonarski Poland	11	93 0.3×	58 0.3×	104 0.8×	22 0.2×	167 2.5×	42	448
Marco Delsante Italy	11	38 0.1×	153 0.9×	271 2.0×	74 0.7×	87 1.3×	30	594
Jianglong Huang China	15	194 0.6×	168 1.0×	21 0.2×	103 1.0×	415 6.2×	54	897
Calogero Lino Cirami Italy	12	39 0.1×	59 0.3×	133 1.0×	52 0.5×	131 2.0×	37	499

Countries citing papers authored by Ian A. Strohbehn

Since Specialization

Citations

This map shows the geographic impact of Ian A. Strohbehn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian A. Strohbehn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian A. Strohbehn more than expected).

Fields of papers citing papers by Ian A. Strohbehn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian A. Strohbehn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian A. Strohbehn. The network helps show where Ian A. Strohbehn may publish in the future.

Co-authorship network of co-authors of Ian A. Strohbehn

This figure shows the co-authorship network connecting the top 25 collaborators of Ian A. Strohbehn. A scholar is included among the top collaborators of Ian A. Strohbehn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian A. Strohbehn. Ian A. Strohbehn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Qiyu, et al.. (2024). Remdesivir and Kidney and Cardiovascular Outcomes in COVID-19 Patients With Reduced GFR. Kidney Medicine. 6(7). 100835–100835. 1 indexed citations

Strohbehn, Ian A., et al.. (2024). The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score–Matched Study. Open Forum Infectious Diseases. 12(1). ofae756–ofae756. 1 indexed citations

Strohbehn, Ian A., Sophia Zhao, Qiyu Wang, et al.. (2023). Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study. The Oncologist. 28(6). e379–e390. 7 indexed citations

Wang, Qiyu, Ian A. Strohbehn, Harish Seethapathy, et al.. (2023). Medication-Related Adverse Events and Discordancies in Cystatin C–Based vs Serum Creatinine–Based Estimated Glomerular Filtration Rate in Patients With Cancer. JAMA Network Open. 6(7). e2321715–e2321715. 16 indexed citations

Strohbehn, Ian A., Qiyu Wang, James G. Dinulos, et al.. (2023). Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancer. npj Breast Cancer. 9(1). 13 indexed citations

Wang, Qiyu, et al.. (2023). Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function. PLoS ONE. 18(2). e0279765–e0279765. 6 indexed citations

Zhao, Sophia, et al.. (2021). Prescription Patterns of Osteoporosis Medications in Patients With Advanced CKD: A Retrospective Cohort Study. Kidney Medicine. 3(6). 1112–1115. 2 indexed citations

Zhao, Sophia, et al.. (2021). A Propensity Score–Matched Observational Study of Remdesivir in Patients with COVID-19 and Severe Kidney Disease. Kidney360. 3(2). 269–278. 16 indexed citations

Strohbehn, Ian A., Sophia Zhao, Harish Seethapathy, et al.. (2021). Acute Kidney Injury Incidence, Recovery, and Long-term Kidney Outcomes Among Hospitalized Patients With COVID-19 and Influenza. Kidney International Reports. 6(10). 2565–2574. 29 indexed citations

10.

Strohbehn, Ian A., et al.. (2021). Curative Therapies for Hepatitis C Virus Infection in Patients with Kidney Disease. Kidney360. 2(8). 1316–1325. 1 indexed citations

11.

Lee, Meghan, Harish Seethapathy, Orhan Efe, et al.. (2020). Dabrafenib-Induced Acute Interstitial Nephritis (AIN) and AKI in Patients with Cancer. Journal of the American Society of Nephrology. 31(10S). 664–664.

12.

Lee, Meghan, Ian A. Strohbehn, Harish Seethapathy, et al.. (2020). Clinical Features of AKI in Patients Receiving Tisagenlecleucel (CAR-T Therapy). Journal of the American Society of Nephrology. 31(10S). 664–664.

13.

Gupta, Shruti, Harish Seethapathy, Ian A. Strohbehn, et al.. (2020). Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma. American Journal of Kidney Diseases. 76(1). 63–71. 80 indexed citations

14.

Seethapathy, Harish, Donald F. Chute, Ian A. Strohbehn, et al.. (2020). Acute Kidney Injury Following Encorafenib and Binimetinib for Metastatic Melanoma. Kidney Medicine. 2(3). 373–375. 7 indexed citations

15.

Danford, Christopher J., Jennifer Y. Lee, Ian A. Strohbehn, Kathleen E. Corey, & Michelle Lai. (2020). Development of an Algorithm to Identify Cases of Nonalcoholic Steatohepatitis Cirrhosis in the Electronic Health Record. Digestive Diseases and Sciences. 66(5). 1452–1460. 6 indexed citations

16.

Seethapathy, Harish, Sophia Zhao, Ian A. Strohbehn, et al.. (2020). Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors. Kidney International Reports. 5(10). 1700–1705. 43 indexed citations

17.

Sise, Meghan E., Ian A. Strohbehn, Donald F. Chute, et al.. (2020). Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C–Viremic Donor to Uninfected Recipient Kidney Transplantation. Kidney International Reports. 5(4). 459–467. 10 indexed citations

18.

Strohbehn, Ian A., Zain Mithani, Jamie S. Hirsch, et al.. (2020). Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m2 or on Renal Replacement Therapy. Kidney International Reports. 6(3). 835–838. 19 indexed citations

19.

Seethapathy, Harish, Meghan Lee, Ian A. Strohbehn, et al.. (2020). Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib. Nephrology Dialysis Transplantation. 37(3). 507–514. 10 indexed citations

20.

Seethapathy, Harish, Sophia Zhao, Donald F. Chute, et al.. (2019). The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors. Clinical Journal of the American Society of Nephrology. 14(12). 1692–1700. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact